EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE

被引：0
|
作者：
Markova, J. [1 ]
Kobe, C. [2 ]
Skopalova, M. [3 ]
Zikavska, L. [1 ]
Vernerova, Z. [1 ]
Klaskova, K. [1 ]
Dedeckova, K. [4 ]
Eich, H. T. [5 ]
Dietlein, M. [2 ]
Fuchs, M. [6 ]
Engert, A. [7 ]
Kozak, T. [1 ]
机构：
[1] Univ Hosp Kralovske Vinohrady, Prague 0, Czech Republic
[2] Univ Cologne, Dept Nucl Med, D-50924 Cologne, Germany
[3] Na Homolce Hosp, PET Ctr, Dept Nucl Med, Prague, Czech Republic
[4] Univ Hosp Na Bulovce, Inst Radiat Oncol, Prague 8, Czech Republic
[5] Univ Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany
[6] Univ Cologne, German Hodgkin Study Grp, D-50924 Cologne, Germany
[7] Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0084
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Feldman, T.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Early interim FDG-PET overshadows the prognostic role of IPS in advanced-stage Hodgkin lymphoma treated by conventional ABVD therapy
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Vitolo, U.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [33] High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
    Kedmi, Meirav
    Apel, Arie
    Davidson, Tima
    Levi, Itai
    Dann, Eldad J.
    Polliack, Aaron
    Ben-Bassat, Isaac
    Nagler, Arnon
    Avigdor, Abraham
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 156 - 161
  • [34] Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
    Chung, Young Shin
    Kim, Hyun-Soo
    Lee, Jung-Yun
    Kang, Won Jun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1211 - 1218
  • [35] High negative predictive value of FDG-PET/CT in assessment of tumor response following RT of SCCHN
    Wang, D.
    Michel, M.
    Campbell, B.
    Massey, B.
    Blumin, J.
    Wong, S.
    Schultz, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S392 - S393
  • [36] Response-adapted therapy using FDG-PET after BEACOPP-chemotherapy in advanced stage Hodgkin's lymphoma - An interim analysis of the German Hodgkin Study Group (GHSG) trial HD15
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Engert, A.
    Kriz, J.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S471 - S471
  • [37] Pet guided beacopp de-escalation in advanced hodgkin lymphoma patients with a good response after the second chemotherapy cycle
    Krochmalczyk, D.
    Jurczak, W.
    Giza, A.
    Zimowska-Curylo, D.
    Sobocinski, M.
    Malkowski, B.
    Pietrzak, T.
    Szefer, J.
    Kumiega, B.
    Skotnicki, A. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 250 - 250
  • [38] Role of Radiotherapy after Assessment of Residual Bulky Tumor using FDG-PET in Patients with Advanced-stage Hodgkin Lymphoma: Final Report of the GHSG HD15 Trial
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Kriz, J.
    Haverkamp, H.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S2 - S3
  • [39] RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD
    Fulbright, Joy M.
    Williams, Sarah E.
    Pahud, Barbara A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 165 - 165
  • [40] FDG-PET guided consolidative radiotherapy in patients with advanced stage Hodgkin lymphoma with residual abnormalities on post chemotherapy CT scan
    Savage, Kerry J.
    Connors, Joseph M.
    Wilson, Don
    Klasa, Richard
    Shenkier, Tamara
    Hoskins, Paul
    Voss, Nicholas
    Sehn, Laurie H.
    BLOOD, 2007, 110 (11) : 70A - 70A
12345